Abstract
Background
Hypoalbuminemia has been identified as a predictor of morbidity and mortality in critically ill patients. There is very little data on the significance and the prognostic value of hypoalbuminemia in patients with aneurysmal subarachnoid hemorrhage (aSAH). This study analyzed the impact of hypoalbuminemia on patient presentation, complications, and outcomes.
Methods
Records of patients admitted with aSAH were examined. Data on baseline characteristics, prevalence of delayed cerebral ischemia, and discharge outcomes were collected. Multivariable logistic regression analysis was performed to assess for associations.
Results
One-hundred and forty-two patients comprised the study cohort (mean age 54.6 ± 13.4), among which 45 (31.5 %) presented with hypoalbuminemia. No difference in baseline characteristics was noted between patients with hypoalbuminemia and those with normal serum albumin. The overall hospital mortality rate was significantly higher in patients with hypoalbuminemia, compared to those with normal albumin (28.9 % vs. 11.3 %; p = 0.04). Hypoalbuminemia was neither associated with delayed cerebral ischemia nor disability at discharge, but independently associated with in-hospital death (odds ratio: 4.26, 95 % confidence interval: 1.09–16.68; p = 0.04).
Conclusion
In patients with aSAH, early hypoalbuminemia is an independent predictor of hospital mortality but not disability at discharge.
Similar content being viewed by others
References
Wong G, Briscoe S, Adnan S, et al. Protein binding of beta-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations? Antimicrob Agents Chemother. 2013;57:6165–70.
Herrmann FR, Safran C, Levkoff SE, et al. Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med. 1992;152:125–30.
Doweiko JP, Nompleggi DJ. Role of albumin in human physiology and pathophysiology. JPEN J Parenter Enteral Nutr. 1991;15:207–11.
Moshage HJ, Janssen JA, Franssen JH, Hafkenscheid JC, Yap SH. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest. 1987;79:1634–5.
Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237:319–34.
Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619–36.
Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8:635–42.
Hopkins SJ, McMahon CJ, Singh N, et al. Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infection. J Neuroinflamm. 2012;9:255.
Badjatia N, Monahan A, Carpenter A, et al. Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage. Neurology. 2015;84:680–7.
Terao Y, Takada M, Tanabe T, Ando Y, Fukusaki M, Sumikawa K. Microalbuminuria is a prognostic predictor in aneurysmal subarachnoid hemorrhage. Intensive Care Med. 2007;33:1000–6.
Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage. A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711–37.
Jellinge ME, Henriksen DP, Hallas P, Brabrand M. Hypoalbuminemia is a strong predictor of 30-day all-cause mortality in acutely admitted medical patients: a prospective, observational, cohort study. PLoS One. 2014;9:e105983.
Lyons O, Whelan B, Bennett K, O’Riordan D, Silke B. Serum albumin as an outcome predictor in hospital emergency medical admissions. Eur J Int Med. 2010;21:17–20.
Caraceni P, Domenicali M, Tovoli A, et al. Clinical indications for the albumin use: still a controversial issue. Eur J Intern Med. 2013;24:721–8.
Jin GX, Li L, Cui SQ, Duan JZ, Wang H. Persistent hypoalbuminemia is a predictor of outcome in cervical spinal cord injury. Spine J. 2014;14:1902–8.
Limaye K, Yang JD, Hinduja A. Role of admission serum albumin levels in patients with intracerebral hemorrhage. Acta Neurol Belg. 2015;. doi:10.1007/s13760-015-0504-2.
Alcázar Lázaro V, Ser Quijano JD, del Hinduja T, Barba Martín R. Hypoalbuminemia and other prognostic factors of mortality at different time points after ischemic stroke. Nutr Hosp. 2013;28:456–63.
Lee YW, Ahn JY, Han IB, Chung YS, Chung SS, Kim NK. The Influence of Hypoalbuminemia on Neurological Outcome in Patients with Subarachnoid Hemorrhage. Kor J Cerebrovascu Surg. 2005;7:109–12.
Pulimood TB, Park GR. Debate: albumin administration should be avoided in the critically ill. Crit Care. 2000;4:151–5.
Kuzuya M, Izawa S, Enoki H, Okada K, Iguchi A. Is serum albumin a good marker for malnutrition in the physically impaired elderly? Clin Nutr. 2007;26:84–90.
Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–54.
Muroi C, Mink S, Seule M, Bellut D, Fandino J, Keller E. Monitoring of the inflammatory response after aneurysmal subarachnoid haemorrhage in the clinical setting: review of literature and report of preliminary clinical experience. Acta Neurochir. 2011;110:191–6.
Ibrahim GM, Macdonald RL. The network topology of aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiat. 2015;86:895–901.
Suarez JI, Martin RH, Calvillo E, et al. Human albumin administration in subarachnoid hemorrhage: results of an international survey. Neurocrit Care. 2014;20:277–86.
Keaney JFJ, Simon DI, Stamler JS, et al. NO forms an adduct with serum albumin that has endothelium derived relaxing factor-like properties. J Clin Invest. 1993;91:1582–9.
Xie Y, Liu W, Zhang X, et al. Human albumin improves long-term behavioral sequelae after subarachnoid hemorrhage through neurovascular remodeling. Crit Care Med. 2015;43:e440–9.
Suarez JI, Martin RH, Calvillo E, et al. The albumin in subarachnoid hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43:683–90.
Dubois MJ, Orellana-Jimenez C, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med. 2006;34:2536–40.
Wilkes MM, Navickis RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med. 2001;135:149–64.
Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998;317:235–40.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of Interest
The authors have nothing to disclose.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Behrouz, R., Godoy, D.A., Topel, C.H. et al. Early Hypoalbuminemia is an Independent Predictor of Mortality in Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care 25, 230–236 (2016). https://doi.org/10.1007/s12028-016-0259-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-016-0259-5